New Total Current Assets from 2010 to 2025
| BBAL Stock | USD 0.0001 0.00 0.00% |
Total Current Assets | First Reported 2010-12-31 | Previous Quarter 9.7 M | Current Value 9.3 M | Quarterly Volatility 583.2 K |
Check New York financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among New York's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 10.2 M or Total Revenue of 44.6 M, as well as many indicators such as Price To Sales Ratio of 0.0454, Dividend Yield of 0.0015 or Days Sales Outstanding of 87.7. New financial statements analysis is a perfect complement when working with New York Valuation or Volatility modules.
New | Total Current Assets | Build AI portfolio with New Stock |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of New York Correlation against competitors. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of New York. If investors know New will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about New York listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of New York Health is measured differently than its book value, which is the value of New that is recorded on the company's balance sheet. Investors also form their own opinion of New York's value that differs from its market value or its book value, called intrinsic value, which is New York's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because New York's market value can be influenced by many factors that don't directly affect New York's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between New York's value and its price as these two are different measures arrived at by different means. Investors typically determine if New York is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, New York's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.